Matthew Young, MD
Family Medicine · Colorado Springs, CONPI 1821060062
Payments from drug & device makers
Across 1,066 payments — averaging $253.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$227K
- Zimmer Biomet$18K
- AbbVie$13K
- AstraZeneca$1K
- Amgen$930
- Lilly USA, LLC$883
- plus $8K from 54 others
What the payments were for
- Consulting fees$12,0504%
- Speaking & faculty fees$173,70864%
- Travel & lodging$35,17513%
- Food & beverage$19,8817%
- Education$50%
- Gifts$28,87511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$269,693 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KorlymMifepristone | 12 | $623,026 |
| Mifepristone | 11 | $359,592 |
| EliquisApixaban | 139 | $168,568 |
| OzempicSemaglutide | 83 | $164,180 |
| FarxigaDapagliflozin Propanediol | 137 | $126,851 |
| MounjaroTirzepatide | 86 | $107,358 |
| TrulicityDulaglutide | 41 | $60,665 |
| Tresiba Flextouch U-200Insulin Degludec | 44 | $52,389 |
| XareltoRivaroxaban | 32 | $46,817 |
| RexultiBrexpiprazole | 26 | $45,842 |
| JardianceEmpagliflozin | 26 | $44,314 |
| TrintellixVortioxetine Hydrobromide | 52 | $40,330 |
| MyrbetriqMirabegron | 36 | $37,233 |
| Repatha SureclickEvolocumab | 37 | $35,220 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $28,277 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Corcept TherapeuticsKorlym | $227,213 | $623,02612 claims |
| PfizerEliquis, Nurtec Odt | $610 | $179,125150 claims |
| Lilly USA, LLCMounjaro, Trulicity | $883 | $168,023127 claims |
| Novo NordiskOzempic | $866 | $164,18083 claims |
| AstraZenecaFarxiga | $1,332 | $126,851137 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $175 | $63,53262 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $80 | $59,17037 claims |
| AbbVieVraylar, Linzess, Synthroid | $12,961 | $51,173152 claims |
| Johnson & JohnsonXarelto | $182 | $46,81732 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $462 | $45,84226 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $858 | $40,33052 claims |
| Astellas Pharma US IncMyrbetriq | $52 | $37,23336 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Colorado Springs
- Ripley HollisterColorado Springs$5.5M
- Lawrence AndrewsColorado Springs$102K
- Jeffrey SnyderColorado Springs$31K
- Elizabeth EricksonColorado Springs$31K
- Daniel RohwederColorado Springs$21K
- Stephen FarkasColorado Springs$20K
- Max NevarezColorado Springs$15K
- Clint FlanaganDacono$7.6M
- Larry OdekirkCastle Rock$6.3M
- Timothy ColanderAurora$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.